TP53 and cancer: Flavokavain B has also been reported to inhibit the uridine-cytidine kinase 2 (UCK2) enzyme in HT-29 cells, resulting in G0/G1 cell cycle arrest and subsequently led to cancer cell death through the MDM2-p53 signaling pathway (50 μM) [138].